Making an inverted Keggin ion lacunary
Chemical Science · 2024 · 15 (41) · 16977-16986
DOI: 10.1039/d4sc04634j ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Science, 2024. Verfasst von Lu-Lu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Advanced Catalytic Engineering Research Center of the Ministry of Education, Hunan University Changsha…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
After a hundred years of waiting, the use of binary heterogroups has succeeded in making an inverted Keggin ion lacunary, the enclosed Mo–oxo framework has been opened up with enhanced Lewis-acid–base catalytic activity.
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, Advanced Catalytic Engineering Research Center of the Ministry of Education, Hunan University Changsha 410082 P. R. China pengyang216@hnu.edu.cn.
- Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education, Faculty of Chemistry, Northeast Normal University Changchun 130024 P. R. China langzl554@nenu.edu.cn.
ORCID-Profile: Zhong-Ling Lang, Peng Yang
Förderung
- Natural Science Foundation of Hunan Province
Zitieren
APA
Liu, L. L., Xu, Z. Y., Yi, P., Chen, C. Q., Lang, Z. L., & Yang, P. (2024). Making an inverted Keggin ion lacunary. Chemical Science, 15(41), 16977-16986. https://doi.org/10.1039/d4sc04634j
Vancouver
Liu LL, Xu ZY, Yi P, Chen CQ, Lang ZL, Yang P. Making an inverted Keggin ion lacunary. Chemical Science. 2024;15(41):16977-16986. doi:10.1039/d4sc04634j
BibTeX
@article{Liu2024,
author = {Liu, Lu-Lu and Xu, Zi-Yu and Yi, Peng and Chen, Chao-Qin and Lang, Zhong-Ling and Yang, Peng},
title = {Making an inverted Keggin ion lacunary},
journal = {Chemical Science},
year = {2024},
volume = {15},
number = {41},
pages = {16977--16986},
doi = {10.1039/d4sc04634j}
}
EUVIMED